Abstract
Glomerulopathies are among the main causes of stage 5 chronic kidney disease and, although numerous treatments are available, there is a growing need for early diagnosis. Therefore, it is important to study sensitive biomarkers that are easy to handle in the clinical practice that allow the detection of the activity of these diseases, including episodes of reactivation. Anti-nephrin is a …